Mostrar el registro sencillo del ítem

dc.contributor.author
Villena, Julio Cesar  
dc.contributor.author
Salva, Maria Susana  
dc.contributor.author
Nuñez, Martha Susana  
dc.contributor.author
Corzo, Josefina  
dc.contributor.author
Tolaba, René  
dc.contributor.author
Faedda, Julio  
dc.contributor.author
Font, Graciela Maria  
dc.contributor.author
Alvarez, Gladis Susana  
dc.date.available
2019-06-05T18:39:16Z  
dc.date.issued
2012-09  
dc.identifier.citation
Villena, Julio Cesar; Salva, Maria Susana; Nuñez, Martha Susana; Corzo, Josefina; Tolaba, René; et al.; Probiotics for Everyone! The Novel Immunobiotic Lactobacillus rhamnosus CRL1505 and the Beginning of Social Probiotic Programs in Argentina; Lifescience Global; International Journal of Biotechnology for Wellness Industries; 1; 3; 9-2012; 189-198  
dc.identifier.issn
1927-3037  
dc.identifier.uri
http://hdl.handle.net/11336/77651  
dc.description.abstract
Lactobacillus rhamnosus CRL1505 (Lr1505) stimulates immune responses in the gut and in the respiratory tract and improves resistance against Salmonella typhimurium and Streptococcus pneumoniae infections in immunocompetent and immunocompromised mice. Considering that respiratory infectious diseases continue to be a major cause of death among preschool children in developing countries, the aim of the present study was to evaluate the effect of Lr1505 on the health of children. A randomized-controlled double-blind clinical trial in 298 healthy children (2-5 years old), attending daycare centers was performed. Yogurt containing Lr1505 was administered to children for 6 months (five times a week). Results were statistically compared with those of children from the same community that received a placebo yogurt (without probiotic). Administration of Lr1505 to young children reduced the incidence of infections: 66% of children in the placebo group presented symptoms of infection while only 34% of cases were detected in the Lr1505 group. Significant differences (P<0.05) were detected in the incidence of intestinal infections, upper respiratory tract infections and angina when placebo and Lr1505 groups were compared. Children fed Lr1505 experienced fewer fevers and needed fewer antibiotics than those receiving the placebo. The protective effect of Lr1505 was associated with increased levels of mucosal IgA antibodies. Lr1505 is a promising resource for the development of prevention strategies against mucosal infections that could be effective tools for medical application. This new probiotic strain has been included into official Nutritional Programs in Argentina and it is given to more than 200 thousand children. This project has encouraged local milk production, thanks to the constant demand of probiotic yogurt containing L. rhamnosus CRL1505 by provincial governments, while incorporating innovation to small and medium enterprises.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Lifescience Global  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Lactobacillus Rhamnosus Crl1505  
dc.subject
Children  
dc.subject
Mucosal Immunity  
dc.subject
Respiratory Infections  
dc.subject.classification
Medicina Critica y de Emergencia  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Probiotics for Everyone! The Novel Immunobiotic Lactobacillus rhamnosus CRL1505 and the Beginning of Social Probiotic Programs in Argentina  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2019-06-04T16:01:08Z  
dc.journal.volume
1  
dc.journal.number
3  
dc.journal.pagination
189-198  
dc.journal.pais
Malasia  
dc.journal.ciudad
Kuala Lumpur  
dc.description.fil
Fil: Villena, Julio Cesar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina  
dc.description.fil
Fil: Salva, Maria Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina  
dc.description.fil
Fil: Nuñez, Martha Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina  
dc.description.fil
Fil: Corzo, Josefina. Ministerio de Salud Pública de Tucumán; Argentina  
dc.description.fil
Fil: Tolaba, René. Universidad Nacional de Tucumán; Argentina  
dc.description.fil
Fil: Faedda, Julio. Hospital del Niño Jeúss de Tucumán; Argentina  
dc.description.fil
Fil: Font, Graciela Maria. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina  
dc.description.fil
Fil: Alvarez, Gladis Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina  
dc.journal.title
International Journal of Biotechnology for Wellness Industries  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.6000/1927-3037/2012.01.03.05  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.lifescienceglobal.com/media/zj_fileseller/files/IJBWIV1N3A05-Alvarez.pdf